Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
RLMD

Updated 10/6/2026, 9:41 AM ET.

RLMD

RELMADA THERAPEUTICS, INC.

Buy$843,990

Shenouda Maged

Chief Financial Officer

200,000 shat $4.22Filed Sep 11, 7:30 AM ETFiling
RLMD

RELMADA THERAPEUTICS, INC.

Buy$828,000

TRAVERSA SERGIO

Chief Executive Officer, Director

200,000 shat $4.14Filed Sep 11, 7:30 AM ETFiling

Read from public SEC filings. Not financial advice.